Asset Details
Do you wish to reserve the book?
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
Do you wish to request the book?
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
2021
Overview
The coronavirus disease 2019 (COVID-19) is a viral disease caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that affects the respiratory system of infected individuals. COVID-19 spreads between humans through respiratory droplets produced when an infected person coughs or sneezes. The COVID-19 outbreak originated in Wuhan, China at the end of 2019. As of 29 Sept 2020, over 235 countries, areas or territories across the globe reported a total of 33,441,919 confirmed cases, and 1,003,497 confirmed deaths due to COVID-19. Individuals of all ages are at risk for infection, but in most cases disease severity is associated with age and pre-existing diseases that compromise immunity, like cancer. Numerous reports suggest that people with cancer can be at higher risk of severe illness and related deaths from COVID-19. Therefore, managing cancer care under this pandemic is challenging and requires a collaborative multidisciplinary approach for optimal care of cancer patients in hospital settings. In this comprehensive review, we discuss the impact of the COVID-19 pandemic on cancer patients, their care, and treatment. Further, this review covers the SARS-CoV-2 pandemic, genome characterization, COVID-19 pathophysiology, and associated signaling pathways in cancer, and the choice of anticancer agents as repurposed drugs for treating COVID-19.
Publisher
Ivyspring International Publisher Pty Ltd,Ivyspring International Publisher
Subject
Antineoplastic Agents - pharmacology
/ Antineoplastic Agents - therapeutic use
/ COVID-19
/ Diabetes
/ Humans
/ Mutation
/ Pandemics - prevention & control
/ Proteins
/ Review
/ Severe acute respiratory syndrome coronavirus 2
/ Signal Transduction - drug effects
/ Signal Transduction - genetics
/ Signal Transduction - immunology
/ Viruses
